Critical review: Privia Health Group (NASDAQ: PRVA) and Babylon (NYSE: BBLN)

Privia Health Group (NASDAQ: PRVAGet a rating) and Babylon (NYSE: BBLNGet a rating) are two medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, dividends, profitability, valuation, earnings, risk and institutional ownership.

Volatility and risk

Privia Health Group has a beta of 1.68, indicating its stock price is 68% more volatile than the S&P 500. Comparatively, Babylon has a beta of 1.21, indicating its stock price is 21% more volatile than the S&P 500.

Insider and Institutional Ownership

63.8% of Privia Health Group shares are held by institutional investors. 57.6% of the shares of Privia Health Group are held by insiders of the company. Strong institutional ownership indicates that hedge funds, endowments, and large fund managers believe a stock will outperform the market over the long term.

Benefits and evaluation

This table compares the revenue, earnings per share and valuation of Privia Health Group and Babylon.

Gross revenue Price/sales ratio Net revenue Earnings per share Price/earnings ratio
Privia Health Group $966.22 million 3.21 -$188.23 million ($2.04) -14.01
Babylon $322.92 million 0.16 -$374.51 million N / A N / A

Privia Health Group has higher revenue and profit than Babylon.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Privia Health Group and Babylon, as provided by

Sales Ratings Hold odds Buy reviews Strong buy odds Rating
Privia Health Group 0 0 11 0 3.00
Babylon 0 3 3 0 2.50

Privia Health Group currently has a consensus target price of $38.09, indicating a potential upside of 33.28%. Babylon has a consensus target price of $6.67, indicating a potential upside of 469.80%. Given Babylon’s higher possible upside, analysts clearly believe that Babylon is more favorable than Privia Health Group.


This table compares the net margins, return on equity and return on assets of Privia Health Group and Babylon.

Net margins Return on equity return on assets
Privia Health Group -19.80% -47.87% -30.88%
Babylon N / A N / A N / A


Privia Health Group beats Babylon on 8 of the 12 factors compared between the two stocks.

About Privia Health Group (Get a rating)

Privia Health Group, Inc. operates as a National Physician Licensing Society in the United States. The company works with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward physicians for delivering care in person and in virtual environments. It offers technology and population health tools to improve independent provider workflows; an organization of management services that allows providers to focus on their patients by reducing administrative work; single TIN medical group that facilitates payer negotiation, clinical integration and financial incentive alignment; an accountable care organization that engages patients, reduces inappropriate use, and improves coordination and patient quality metrics to support value-based care; and a network for buyers and payers that allows providers to connect with new patient populations and create personalized contracts. The company was founded in 2007 and is based in Arlington, Virginia. Privia Health Group, Inc. was a former subsidiary of Brighton Health Group Holdings, LLC.

About Babylon (Get a rating)

Babylon Holdings Limited operates as a digital healthcare company. It offers an end-to-end care solution that leverages its digital health suite, virtual care, in-person medical care, and post-care offerings. The company also provides Babylon Cloud services. It operates in the UK, USA, Asia-Pacific, Canada and internationally. The company was founded in 2013 and is based in London, UK.

Receive daily news and reviews for Privia Health Group – Enter your email address below to receive a concise daily summary of the latest news and analyst ratings for Privia Health Group and related companies with’s FREE daily email newsletter.

Comments are closed.